Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome
- PMID: 19214546
- DOI: 10.1007/s00404-009-0958-7
Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome
Abstract
Purpose: To investigate the correlation between serum 25-hydroxyvitamin D (25-OH-VD) concentrations and metabolic parameters in obese and non-obese women with polycystic ovary syndrome (PCOS).
Methods: One hundred women with PCOS were divided into two groups, obese and non-obese, according to their body mass index (BMI). Waist-to-hip ratio (WHR), Ferriman-Gallwey score, homeostasis model assessment of insulin resistance (HOMA-IR), total cholesterol, triglycerides, calcium, 25-OH-VD, LH/FSH, total testosterone, and DHEAS were measured.
Results: The serum 25-OH-VD mean levels were 56.31% lower in the obese PCOS patients. There was an association of increased HOMA-IR, BMI, WHR, triglycerides, total testosterone, and DHEAS with decreased 25-OH-VD concentrations in the obese PCOS patients.
Conclusion: Low serum 25-OH-VD concentrations result from the presence of obesity and insulin resistance. However, the dependency between PCOS and hypovitaminosis D is questionable. Hypovitaminosis D should be kept in mind while managing obese women with PCOS.
Similar articles
-
Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.Exp Clin Endocrinol Diabetes. 2006 Nov;114(10):577-83. doi: 10.1055/s-2006-948308. Exp Clin Endocrinol Diabetes. 2006. PMID: 17177140
-
Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome.Med Glas (Zenica). 2014 Feb;11(1):170-6. Med Glas (Zenica). 2014. PMID: 24496360
-
Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.J Steroid Biochem Mol Biol. 2018 Mar;177:209-215. doi: 10.1016/j.jsbmb.2017.07.012. Epub 2017 Jul 19. J Steroid Biochem Mol Biol. 2018. PMID: 28734987
-
Vitamin D predictors in polycystic ovary syndrome: a meta-analysis.Eur J Clin Invest. 2017 Oct;47(10):746-755. doi: 10.1111/eci.12800. Epub 2017 Sep 7. Eur J Clin Invest. 2017. PMID: 28795765 Review.
-
[The role of vitamin D deficiency in the etiology of polycystic ovary syndrome disorders].Ginekol Pol. 2013 Jun;84(6):456-60. doi: 10.17772/gp/1604. Ginekol Pol. 2013. PMID: 24032264 Review. Polish.
Cited by
-
Association between Hypoadiponectinemia and Low Serum Concentrations of Calcium and Vitamin D in Women with Polycystic Ovary Syndrome.ISRN Endocrinol. 2012;2012:949427. doi: 10.5402/2012/949427. Epub 2012 Jan 16. ISRN Endocrinol. 2012. PMID: 22363895 Free PMC article.
-
Vitamin D levels and lipid profiles in patients with polycystic ovary syndrome.BMC Womens Health. 2024 Aug 27;24(1):472. doi: 10.1186/s12905-024-03294-7. BMC Womens Health. 2024. PMID: 39192256 Free PMC article.
-
Association of VDBP and CYP2R1 gene polymorphisms with vitamin D status in women with polycystic ovarian syndrome: a north Indian study.Eur J Nutr. 2018 Mar;57(2):703-711. doi: 10.1007/s00394-016-1357-z. Epub 2016 Dec 23. Eur J Nutr. 2018. PMID: 28008453
-
Vitamin D and calcium intake and risk of early menopause.Am J Clin Nutr. 2017 Jun;105(6):1493-1501. doi: 10.3945/ajcn.116.145607. Epub 2017 May 10. Am J Clin Nutr. 2017. PMID: 28490509 Free PMC article.
-
Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: a case control study.BMC Endocr Disord. 2019 Dec 23;19(1):145. doi: 10.1186/s12902-019-0477-x. BMC Endocr Disord. 2019. PMID: 31870342 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical